Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Pharmakon Labs

This article was originally published in The Tan Sheet

Executive Summary

Pharmakon Labs: Orasept oral anesthetic, antiseptic and astringent contains tannic acid, which is not GRAS/E as a cold sore and fever blister treatment ingredient, rendering the product mislabeled, FDA told the firm in a recent warning letter. However, "even without the presence of tannic acid in the formulation for Orasept, the product is a `new drug' because of claims for gingivitis and herpes simplex cold sores found in the labeling" and is misbranded because it fails to bear adequate directions for use, the agency notes...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085954

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel